Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
A Hawaii judge ruled the FDA broke the law by keeping strict rules on mifepristone without proper justification.
A federal judge in Hawaii ruled the FDA violated the law by maintaining restrictive regulations on mifepristone, finding the agency failed to provide a reasoned justification for rules like prescriber and pharmacy certification and mandatory counseling forms.
The decision, stemming from an ACLU lawsuit, comes amid ongoing legal and political battles over access to the drug, which has been deemed safe and effective for 25 years.
While the judge ordered the FDA to reconsider ignored evidence, current restrictions remain in place.
The case, which began in 2017 and spans multiple administrations, highlights concerns that the rules disproportionately affect low-income and rural patients.
The FDA previously removed the in-person pickup requirement, but other barriers persist.
The ruling underscores growing scrutiny of mifepristone’s regulation, especially under potential Republican leadership, though the Justice Department has not commented.
Hawaii allows abortion until fetal viability and in cases where a patient’s life or health is at risk.
Un juez de Hawai dictaminó que la FDA violó la ley al mantener reglas estrictas sobre la mifepristona sin una justificación adecuada.